Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Ian Wee Jun Yan, Beverly Lim Tian Ying & Frank Brennan. (2018) Public Policy: An Analgesia for Opioid Diversion. Journal of Pain & Palliative Care Pharmacotherapy 32:2-3, pages 178-191.
Read now
Read now
Zanib Mohammed, Gareth J. Hughes, Philippa Hearty & Nat M. J. Wright. (2016) The perceived and actual consequences of intranasal administration of buprenorphine or burprenorphine–naloxone by prisoners. Drugs: Education, Prevention and Policy 23:2, pages 99-102.
Read now
Read now
Sofie Mauger, Ronald Fraser & Kathryn Gill. (2014) Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence. Neuropsychiatric Disease and Treatment 10, pages 587-598.
Read now
Read now
MathiasB. Forrester. (2012) Temporal and Geographic Patterns in Opioid Abuse in Texas. Journal of Addictive Diseases 31:2, pages 93-99.
Read now
Read now
Adam R. Winstock & Toby Lea. (2010) Diversion and Injection of Methadone and Buprenorphine Among Clients in Public Opioid Treatment Clinics in New South Wales, Australia. Substance Use & Misuse 45:1-2, pages 240-252.
Read now
Read now
Kristie Mammen & James Bell. (2009) The clinical efficacy and abuse potential of combination buprenorphine–naloxone in the treatment of opioid dependence. Expert Opinion on Pharmacotherapy 10:15, pages 2537-2544.
Read now
Read now
Shannon Gwin Mitchell, Sharon M. Kelly, Barry S. Brown, Heather Schacht Reisinger, James A. Peterson, Adrienne Ruhf, Michael H. Agar, Kevin E. O'Grady & Robert P. Schwartz. (2009) Uses of Diverted Methadone and Buprenorphine by Opioid-Addicted Individuals in Baltimore, Maryland. American Journal on Addictions 18:5, pages 346-355.
Read now
Read now
AndrewA. Monte, Todd Mandell, BonnieB. Wilford, Joseph Tennyson & EdwardW. Boyer. (2009) Diversion of Buprenorphine/Naloxone Coformulated Tablets in a Region with High Prescribing Prevalence. Journal of Addictive Diseases 28:3, pages 226-231.
Read now
Read now
Adam R. Winstock. (2008) Buprenorphine use by the smoking route in gaols in NSW. Drug and Alcohol Review 27:4, pages 449-450.
Read now
Read now
Articles from other publishers (19)
Perry M. Duncan. 2020. Substance Use Disorders. Substance Use Disorders.
Naveen K. Dhagudu, Atul Ambekar, Alok Agrawal, Ravindra Rao, Ashwani K. Mishra, Raka Jain & Shalini Singh. (2020) Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double‐blind, within‐subject, crossover study among opioid‐dependent subjects. Drug and Alcohol Review 39:5, pages 595-603.
Crossref
Crossref
Saumitra V. Rege, Duc Anh Ngo, Nassima Ait-Daoud, Justin Rizer, Sana Sharma & Christopher P. Holstege. (2020) Epidemiology of pediatric buprenorphine and methadone exposures reported to the poison centers. Annals of Epidemiology 42, pages 50-57.e2.
Crossref
Crossref
Xiaofan Li, Daryl Shorter & Thomas Kosten. (2015) Prescription Opioid Misuse: Effective Methods for Reducing the Epidemic. Current Treatment Options in Psychiatry 2:2, pages 122-135.
Crossref
Crossref
Nat M.J. Wright, Zanib Mohammed & Gareth J. Hughes. (2014) Comparative prices of diverted buprenorphine/naloxone and buprenorphine in a UK prison setting: A cross-sectional survey of drug using prisoners. Drug and Alcohol Dependence 144, pages 254-258.
Crossref
Crossref
Hanna Uosukainen, Jenni Ilomäki, Jussi Kauhanen, Ulrich Tacke, Jaana Föhr, Jari Tiihonen & J. Simon Bell. (2014) Factors associated with buprenorphine compared to amphetamine abuse among clients seeking treatment in Finland. Journal of Substance Abuse Treatment 46:5, pages 561-566.
Crossref
Crossref
Theresa A. Cassidy, Pronabesh DasMahapatra, Ryan A. Black, Matthew S. Wieman & Stephen F. Butler. (2014) Changes in Prevalence of Prescription Opioid Abuse after Introduction of an Abuse-Deterrent Opioid Formulation. Pain Medicine 15:3, pages 440-451.
Crossref
Crossref
Becky L. Genberg, Mirinda Gillespie, Charles R. Schuster, Chris-Ellyn Johanson, Jacquie Astemborski, Gregory D. Kirk, David Vlahov & Shruti H. Mehta. (2013) Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland. Addictive Behaviors 38:12, pages 2868-2873.
Crossref
Crossref
Samantha Lee, Wendy Klein-Schwartz, Christopher Welsh & Suzanne Doyon. (2013) Medical Outcomes Associated with Nonmedical Use of Methadone and Buprenorphine. The Journal of Emergency Medicine 45:2, pages 199-205.
Crossref
Crossref
Raminta Daniulaityte, Russel Falck & Robert G. Carlson. (2012) Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids. Drug and Alcohol Dependence 122:3, pages 201-207.
Crossref
Crossref
Donald G. Barceloux. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse
514
526
.
Heather Hamza & Ethan O. Bryson. (2012) Buprenorphine Maintenance Therapy in Opioid-Addicted Health Care Professionals Returning to Clinical Practice: A Hidden Controversy. Mayo Clinic Proceedings 87:3, pages 260-267.
Crossref
Crossref
Chris-Ellyn Johanson, Cynthia L. Arfken, Salvatore di Menza & Charles Roberts Schuster. (2012) Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians. Drug and Alcohol Dependence 120:1-3, pages 190-195.
Crossref
Crossref
Alexander R. Bazazi, Michael Yokell, Jeannia J. Fu, Josiah D. Rich & Nickolas D. Zaller. (2011) Illicit Use of Buprenorphine/Naloxone Among Injecting and Noninjecting Opioid Users. Journal of Addiction Medicine 5:3, pages 175-180.
Crossref
Crossref
Ernest V. Pedapati & Scot T. Bateman. (2011) Toddlers requiring pediatric intensive care unit admission following at-home exposure to buprenorphine/naloxone. Pediatric Critical Care Medicine 12:2, pages e102-e107.
Crossref
Crossref
James Bell. (2010) The Global Diversion of Pharmaceutical Drugs. Addiction 105:9, pages 1531-1537.
Crossref
Crossref
Shannon Gwin Mitchell, Sharon M. Kelly, Barry S. Brown, Heather Schacht Reisinger, James A. Peterson, Adrienne Ruhf, Michael H. Agar, Kevin E. O'Grady & Robert P. Schwartz. (2010) Uses of Diverted Methadone and Buprenorphine by Opioid‐Addicted Individuals in Baltimore, Maryland. The American Journal on Addictions 18:5, pages 346-355.
Crossref
Crossref
Lynn Webster. (2009) Update on Abuse-Resistant and Abuse-Deterrent Approaches to Opioid Formulations. Pain Medicine 10:suppl 2, pages S124-S133.
Crossref
Crossref
C. N. E. Tompkins, N. M. J. Wright, M. G. Waterman & L. Sheard. (2009) Exploring prison buprenorphine misuse in the United Kingdom: A qualitative study of former prisoners. International Journal of Prisoner Health 5:2, pages 71-87.
Crossref
Crossref